Congratulations to Team Not Yet Net, our #1 fundraising team from the Twilight 5K!
Not Yet Net raised an impressive $11,893 to help the fight against cancer in Maine.
The team enjoyed a night out in the WMTW/8 Skybox at the Portland Seadogs and enjoyed refreshments provided by Town & Country Federal Credit Union.
PORTLAND, Maine — The Bristol-Myers Squibb Foundation has awarded a $5 million grant to Maine Medical Center (MMC) for the creation of a statewide initiative to improve the prevention, early detection and treatment of lung cancer in Maine, where incidence rates and deaths due to lung cancer are among the highest in the nation, according to the Centers for Disease Control and Prevention.
The Maine Lung Cancer Prevention and Screening (Maine LungCAPS) Initiative is a four-year multi-institution, multi-disciplinary collaboration of Maine health care providers and stakeholders.
$5.6 million grant award to create state-wide prevention and screening program
There is a harsh reality facing the people of Maine: local lung cancer rates are among the highest in the nation and the leading cause of cancer deaths in the state. For years, an ad-hoc network of isolated programs have struggled to make improvements, but one Maine physician is ready to take on the entire spectrum of cancer screening, prevention and treatment in a bid save move lives.
Paul Han, MD, MA, MPH, director of the Center for Outcomes Research and Evaluation at the MMC Research Institute, is the Principal Investigator for the recently announced Maine LungCAPS initiative, a program designed to improve the prevention, early detection and treatment of lung cancer in Maine.
MCF: What drew you toward a career in medicine?